All In Biotech

Drug Trial Radar · NCT04404361

PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer

A Phase 2 Randomized, Double-blind, Placebo-controlled, Multicenter Study of Pacritinib Plus Standard of Care Versus Placebo and Standard of Care in Hospitalized Patients With Severe COVID-19 With or Without Cancer

Last checked: Nov 20, 2026Latest source record: Jun 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingRandomized with 200 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

200

Actual

Start

May 22, 2020

Primary completion

Sep 21, 2021

Study completion Sep 21, 2021

Sponsor

Lead sponsor
CTI BioPharmaIndustry
Sponsor type
Industry
First posted
May 27, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 2 randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of pacritinib in hospitalized patients with severe COVID-19 with or without cancer.

Conditions

  • COVID19
  • COVID-19
  • COVID

Interventions

  • PacritinibDrug

    100 mg capsules

  • PlaceboDrug

    Placebo capsules matching pacritinib 100 mg capsules

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Progression to IMV and/or ECMO or DeathTime frame: Baseline to Day 28

Locations

21 sites in 1 country. Site status is shown where the registry gives one.

  • St. Jude Hospital Yorba Linda dba St. Joseph Heritage Healthcare

    Orange, California

  • Ascension St. Vincent's Riverside Hospital

    Jacksonville, Florida

  • Grady Memorial Hospital

    Atlanta, Georgia

  • St. Vincent Medical Group, Inc

    Indianapolis, Indiana

  • St. Agnes Healthcare

    Baltimore, Maryland

  • Brigham and Women's Hospital

    Boston, Massachusetts

  • University of Michigan

    Ann Arbor, Michigan

  • Ascension St. John Hospital

    Detroit, Michigan

  • Ascension Providence Hospital - Novi Campus

    Novi, Michigan

  • Providence Cancer Institute

    Southfield, Michigan

  • Atlantic Melanoma Center

    Morristown, New Jersey

  • Overlook Medical Center

    Morristown, New Jersey

  • Chilton Medical Center

    Pompton Plains, New Jersey

  • Mount Sinai Medical Center

    New York, New York

  • The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital

    Cincinnati, Ohio

  • St. John Medical Center

    Tulsa, Oklahoma

  • Albert Einstein Medical Center

    Philadelphia, Pennsylvania

  • Rhode Island Hospital

    Providence, Rhode Island

  • The Miriam Hospital

    Providence, Rhode Island

  • Ascension St. Francis Hospital

    Milwaukee, Wisconsin

  • Ascension All Saints

    Racine, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.